Matthew Gold
Impact in
-
- Antibiotic Use and Resistance
-
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Cardiomyopathy and Myosin Studies 3
- Cardiovascular Function and Risk Factors 2
- Surgery 5
- Coronary Interventions and Diagnostics 3
- Lipoproteins and Cardiovascular Health 2
- Co-authors
- David Pitrak (1 shared paper)Gökhan M. Mutlu (1 shared paper)Jeffrey Mueller (1 shared paper)Lucas Kimmig (1 shared paper)David Wu (1 shared paper)Ece Mutlu (1 shared paper)Aliya N. Husain (1 shared paper)Natasha N. Pettit (1 shared paper)
- Journals
- Journal of the American Heart Association (3 papers)International Journal of Cardiology (2 papers)The American Journal of Cardiology (2 papers)Journal of Alzheimer s Disease (1 paper)Circulation Genomic and Precision Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Matthew Gold
20 papers receiving 259 citations
Peers
Comparison fields: 5 of 68
- Applied Microbiology and Biotechnology 14
- Infectious Diseases 100
- Neurology 37
- Critical Care and Intensive Care Medicine 11
- Emergency Medicine 14
Countries citing papers authored by Matthew Gold
This map shows the geographic impact of Matthew Gold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Gold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Gold more than expected).
Fields of papers citing papers by Matthew Gold
This network shows the impact of papers produced by Matthew Gold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Gold. The network helps show where Matthew Gold may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Gold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 125 | |
| 2 | 2019 | 41 | |
| 3 | 1998 | 27 | |
| 4 | Racial differentials in the identification of hypercholesterolemia. | 1993 | 22 |
| 5 | 2023 | 8 | |
| 6 | 2020 | 7 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 5 | |
| 9 | 2019 | 5 | |
| 10 | 2025 | 4 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2024 | 1 |
About Matthew Gold
Matthew Gold is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 268 indexed citations. Recurring topics across this work include Cardiac Imaging and Diagnostics (3 papers), Coronary Interventions and Diagnostics (3 papers), Cardiomyopathy and Myosin Studies (3 papers), Cardiovascular Function and Risk Factors (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Trypanosoma species research and implications (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (14 citations), Infectious Diseases (100 citations), Neurology (37 citations), Critical Care and Intensive Care Medicine (11 citations) and Emergency Medicine (14 citations). Matthew Gold has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include David Pitrak, Gökhan M. Mutlu, Jeffrey Mueller, Lucas Kimmig, David Wu, Ece Mutlu, Aliya N. Husain, Natasha N. Pettit, Daniel Wojdyla and Ann Marie Návar. Their work appears in journals such as Journal of the American Heart Association, International Journal of Cardiology, The American Journal of Cardiology, Journal of Alzheimer s Disease and Circulation Genomic and Precision Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.